Eng

ReTo Announces Filing of Annual Report on Form 20-F

PR Newswire (美通社)
更新於 05月16日00:15 • 發布於 05月16日00:00 • PR Newswire

BEIJING, May 16, 2024 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and Internet of Things technology development services in China and other countries, today announced the filing of its annual report on Form 20-F, containing audited consolidated financial statements for the fiscal year ended December 31, 2023, with the Securities and Exchange Commission on May 15, 2024. A copy of the annual report is available on its website (). Shareholders may also receive a hard copy of the annual report free of charge upon request.

About ReTo Eco-Solutions, Inc.

Founded in 1999, ReTo Eco-Solutions, Inc., through its proprietary technologies, systems and solutions, is striving to bring clean water and fertile soil to communities worldwide. The Company, through its operating subsidiaries in China, is engaged in the ecological restoration and solid waste treatment, manufacturing and distribution of eco-friendly construction materials (aggregates, bricks, pavers and tiles) made from mining waste (iron tailings), and soil remediation materials transformed from solid waste (iron tailings), as well as equipment used for the production of these eco-friendly construction materials and soil remediation materials. In addition, the Company provides consultation, design, project implementation and construction of urban ecological protection projects and parts, engineering support, consulting, technical advice and service, and other project-related solutions for its manufacturing equipment and environmental protection projects. The Company also offers roadside assistance services and technology development services utilizing Internet of Things technologies. For more information, please visit: .

廣告(請繼續閱讀本文)

For more information, please contact:

ReTo Eco-Solutions, Inc.
Angela Hu
Beijing Phone: +86-010-64827328
or

廣告(請繼續閱讀本文)
查看原始文章

更多 Eng 相關文章

Huawei's David Wang: UBB Advanced Paves the Way to All Intelligence
PR Newswire (美通社)
SunAzure Introduces De Antonio as Hong Kong's Exclusive Distributor, Ushering in a New Era of Luxurious, High-Performance Yachting
PR Newswire (美通社)
Global Times: Generations of 'temple caretakers,' dedicated to relics preservation, embody China's unwavering commitment to building a cultural powerhouse
PR Newswire (美通社)
TPIsoftware and Taipei Medical Alliance Sign MOU to Advance Healthcare Technology and Medical Research
PR Newswire (美通社)
Matrixport Launches Exclusive Structured Product "Buy Now Pay Later", Pioneering Crypto Financial Derivatives Development
PR Newswire (美通社)
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab
PR Newswire (美通社)
Otis Appoints Nicolas Lopez as Managing Director of Southeast Asia
PR Newswire (美通社)
ZEEKR Announces October 2024 Delivery Update
PR Newswire (美通社)
GLOBALink | UK unveils new budget with tax hikes of 40 bln pounds
XINHUA
HKBN Appoints Dr Gabriel Leung as Chief Executive Officer - Enterprise Solutions
PR Newswire (美通社)
ANGEL Shines at FHA HoReCa 2024 with Leading Water Purification Solutions
PR Newswire (美通社)
National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment
PR Newswire (美通社)
Xu Bing, Co-founder of SenseTime: Ignoring AI Infrastructure Investment Poses Greater Risks than Taking Action
PR Newswire (美通社)
Prime Minister Fico's visit reflects positive aspects of China-Europe relations: Global Times editorial
PR Newswire (美通社)
How Taiwan Is Innovating to Nourish East Asia's Modern Consumers
PR Newswire (美通社)
Hezbollah's new leader says to continue his predecessor's war strategy
XINHUA
Global Young Leaders Dialogue Jiangxi Smart Tour: Inheritance and Innovation in Yichun
PR Newswire (美通社)
TPIsoftware and Taipei Medical Alliance Sign MOU to Advance Healthcare Technology and Medical Research
PR Newswire (美通社)
CARsgen® U.S. Clinical Holds Lifted by FDA
PR Newswire (美通社)